Literature DB >> 2154808

Morphine-6-glucuronide is more mu-selective and potent in analgesic tests than morphine.

B Francés1, R Gout, G Campistron, E Panconi, J Cros.   

Abstract

6-glucuronidation of morphine confers to this widely used analgesic increased potencies both in terms of receptor binding (selectivity) and of antinociceptive properties. In binding studies, 6-glucuronidation of morphine results in increased mu/kappa selectivity (comparable to DAGO). Na+ ions and Gpp(NH)p inhibit similarly the binding of morphine and M6G at the mu sites, suggesting that M6G is a mu agonist. The agonist nature of M6G was further confirmed by its antinociceptive properties: M6G (i.c.v.) was considerably more potent than morphine in the writhing (45 fold) and in the tail-flick (61 fold) tests. Furthermore, M6G induced a longer lasting analgesic effect than morphine. These data strongly suggest that M6G may significantly contribute to the pharmacological activity of morphine.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2154808

Source DB:  PubMed          Journal:  Prog Clin Biol Res        ISSN: 0361-7742


  12 in total

1.  Morphine-6 beta-glucuronide has a higher efficacy than morphine as a mu-opioid receptor agonist in the rat locus coeruleus.

Authors:  P B Osborne; B Chieng; M J Christie
Journal:  Br J Pharmacol       Date:  2000-12       Impact factor: 8.739

Review 2.  Role of active metabolites in the use of opioids.

Authors:  Janet K Coller; Lona L Christrup; Andrew A Somogyi
Journal:  Eur J Clin Pharmacol       Date:  2008-10-29       Impact factor: 2.953

Review 3.  Drug disposition alterations in liver disease: extrahepatic effects in cholestasis and nonalcoholic steatohepatitis.

Authors:  Mark J Canet; Nathan J Cherrington
Journal:  Expert Opin Drug Metab Toxicol       Date:  2014-07-03       Impact factor: 4.481

4.  Effects of morphine metabolites on micturition in normal, unanaesthetized rats.

Authors:  Y Igawa; D Westerling; A Mattiasson; K E Andersson
Journal:  Br J Pharmacol       Date:  1993-09       Impact factor: 8.739

5.  Low-dose morphine elicits ventilatory excitant and depressant responses in conscious rats: Role of peripheral μ-opioid receptors.

Authors:  Fraser Henderson; Walter J May; Ryan B Gruber; Alex P Young; Lisa A Palmer; Benjamin Gaston; Stephen J Lewis
Journal:  Open J Mol Integr Physiol       Date:  2013-08-01

Review 6.  Morphine-6-glucuronide: an analgesic of the future?

Authors:  J Lötsch; G Geisslinger
Journal:  Clin Pharmacokinet       Date:  2001       Impact factor: 6.447

Review 7.  Glucuronidation of drugs. A re-evaluation of the pharmacological significance of the conjugates and modulating factors.

Authors:  H K Kroemer; U Klotz
Journal:  Clin Pharmacokinet       Date:  1992-10       Impact factor: 6.447

8.  Bilateral carotid sinus nerve transection exacerbates morphine-induced respiratory depression.

Authors:  Santhosh M Baby; Ryan B Gruber; Alex P Young; Peter M MacFarlane; Luc J Teppema; Stephen J Lewis
Journal:  Eur J Pharmacol       Date:  2018-07-19       Impact factor: 4.432

9.  The Human UGT2B7 Nanodisc.

Authors:  Ian Cook; Anna B Asenjo; Hernando Sosa; Thomas S Leyh
Journal:  Drug Metab Dispos       Date:  2019-12-31       Impact factor: 3.922

Review 10.  Medications for analgesia and sedation in the intensive care unit: an overview.

Authors:  Diederik Gommers; Jan Bakker
Journal:  Crit Care       Date:  2008-05-14       Impact factor: 9.097

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.